zoloft 50 mg
upjohn eesv - sertralinhydroklorid - tablett, filmdrasjert - 50 mg
zoloft 25 mg
upjohn eesv - sertralinhydroklorid - tablett, filmdrasjert - 25 mg
zoloft 100 mg
upjohn eesv - sertralinhydroklorid - tablett, filmdrasjert - 100 mg
ozalin 2 mg/ ml
primex pharmaceuticals oy - midazolam - mikstur, oppløsning i endosebeholder - 2 mg/ ml
sertraline accord 50 mg
accord healthcare b.v. - sertralinhydroklorid - tablett, filmdrasjert - 50 mg
sertraline accord 100 mg
accord healthcare b.v. - sertralinhydroklorid - tablett, filmdrasjert - 100 mg
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
utrogestan 300 mg
besins healthcare ireland limited (1) - progesteron - vaginalkapsel, myk - 300 mg
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiske midler - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
tolvaptan teva b.v. 30 mg / 90 mg
teva b.v. - tolvaptan - tablett - 30 mg / 90 mg